Trial Profile
Long term cardiac safety and tolerability of Fingolimod in Multiple Sclerosis: A post-marketing study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2015
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions
- 04 Nov 2015 New trial record